D-0568-2022 Class II Terminated
FDA drug recall D-0568-2022 was initiated by ANI Pharmaceuticals, Inc. on Feb 15, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 25, 2022). Affected quantity: 5,477 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 23, 2022
- Initiation Date
- Feb 15, 2022
- Termination Date
- Oct 25, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,477 bottles
Product description
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
Reason for recall
cGMP Deviations
Distribution pattern
Nationwide within the United States
Code information
Lot #: 19B064A, Exp. Date 03/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0568-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026